Bouchey Financial Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bouchey Financial Group’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-116,745	Closed	-$3.29M	–	75
2018 Q4	$3.29M	Buy	116,745 +111,620	+2,178%	+$3.7M	0.93%	27
2018 Q3	$202K	Sell	5,125 -700	-12%	-$26.6K	0.05%	75
2018 Q2	$217K	Sell	5,825 -50	-0.9%	-$1.81K	0.06%	63
2018 Q1	$201K	Buy	+5,875	New	+$206K	0.06%	67

Other funds holding SBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

WIA

Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return

Bouchey Financial Group's SBIO Position: Q1 2019 in Review

Bouchey Financial Group sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2019, closing a stake of 116,745 shares — an estimated $3.29M sold.

Bouchey Financial Group first reported a position in SBIO in Q1 2018 and held it in 4 quarters. The position peaked at $3.29M in Q4 2018. 47 funds tracked by Wall St. Rank hold SBIO as of Q1 2019.

Bouchey Financial Group reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2019 after selling out during the quarter.
Bouchey Financial Group sold 116,745 ALPS Medical Breakthroughs ETF shares in Q1 2019, an estimated $3.29M.
Bouchey Financial Group first reported a position in ALPS Medical Breakthroughs ETF in Q1 2018 and held it in 4 quarters.
Bouchey Financial Group's ALPS Medical Breakthroughs ETF position peaked at $3.29M in Q4 2018.
47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2019.

Based on Bouchey Financial Group's 13F filing for Q1 2019, filed 10 Apr 2019.